Equity Details
Price & Market Data
Price: $28.18
Daily Change: +$0.35 / 1.24%
Daily Range: $27.38 - $28.56
Market Cap: $1,403,034,240
Daily Volume: 902,029
Performance Metrics
1 Week: 2.66%
1 Month: 4.99%
3 Months: 62.89%
6 Months: 6.14%
1 Year: 39.02%
YTD: 22.04%
About STAAR Surgical Company (STAA)
Your comprehensive guide to STAAR Surgical Company (STAA). Price: 28.18, daily change: +$0.35 / 1.24%. Market cap: 1,403,034,240. Full range of performance data for investors.
Company Details
Employees: 957
Sector: Health technology
Industry: Medical specialties
Country: United States
Details
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company offers implantable collamer lens product family (ICLs) comprising EVO ICL, EVO+ ICL, EVO Visian ICL, and EVO Viva ICL for use in refractive surgery for the treatment of visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as ophthalmologists. The company sells its products directly through its sales representatives in Japan, the United States, Germany, Spain, Singapore, Canada, and the United Kingdom, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.